{"gene":"PKIA","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2020,"finding":"PKIA (PKIα) binds PKA with high affinity and blocks its kinase activity, thereby diverting GPCR-Gαs-cAMP signaling away from PKA and toward EPAC-RAP1 and MAPK activation. Overexpression of PKIA increases intracellular cAMP (by relieving PKA-mediated negative feedback on cAMP), enhances EPAC and ERK activation, and promotes tumor cell migration and growth. Depletion of PKIA in prostate cancer cells reduces migration, increases sensitivity to anoikis, and reduces tumor growth.","method":"PKI overexpression and depletion (knockdown) in cell lines measuring MAPK pathway activation, cAMP levels, EPAC-RAP1 activation, migration assay, anoikis assay, tumor growth assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO/OE with defined cellular phenotype and pathway placement (EPAC-RAP1-ERK), multiple orthogonal readouts in a single lab","pmids":["32830375"],"is_preprint":false},{"year":2020,"finding":"Angiotensin-(1-9) upregulates miR-129, which decreases PKIA transcript levels, resulting in activation of PKA signaling. PKA activity downstream of PKIA suppression is necessary for angiotensin-(1-9)-mediated mitochondrial fusion (via DRP1 phosphorylation), prevention of mitochondrial fission and calcium dysregulation, and anti-hypertrophic effects on cardiomyocytes.","method":"RNA-seq to identify miR-129 upregulation; miR-129 overexpression/inhibition; Western blot for PKIA and PKA targets; PKA activity assays; measurement of mitochondrial morphology and calcium handling; calcineurin/NFAT pathway readouts in cardiomyocyte hypertrophy model","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (RNA-seq, functional miRNA manipulation, PKA activity measurement, mitochondrial morphology), single lab","pmids":["32152556"],"is_preprint":false},{"year":2024,"finding":"PKIA overexpression elevates intracellular cAMP but suppresses PKA activity, instead activating the noncanonical EPAC-Rap1-ERK pathway to promote drug efflux and cell survival in vincristine-resistant Ewing sarcoma. Pharmacological inhibition of EPAC reversed resistance, and PKIA knockdown restored vincristine sensitivity in xenografts.","method":"Transcriptomic analysis of vincristine-resistant cells; PKIA overexpression and knockdown; cAMP and PKA activity measurements; EPAC inhibitor (ESI-09) treatment; IC50 assays; xenograft models","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO/OE with defined pathway (cAMP-EPAC-Rap1-ERK), in vivo xenograft validation, pharmacological rescue, single lab","pmids":["41313792"],"is_preprint":false},{"year":2024,"finding":"Dronedarone activates SIRT1, which deacetylates FOXO3, leading to FOXO3 transcriptional upregulation of PKIA. Elevated PKIA in turn suppresses PKA activity and attenuates myocardial hypertrophy. JASPAR/luciferase assays confirmed FOXO3 binding to the PKIA promoter.","method":"SIRT1/FOXO3 overexpression and silencing in Ang II-treated H9C2 cells; JASPAR prediction and luciferase reporter assay for FOXO3-PKIA promoter interaction; RT-qPCR and Western blot; TAC rat model; crystal violet and rhodamine phalloidin staining for cell size","journal":"Korean circulation journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter validates direct promoter binding, multiple genetic manipulations, in vivo TAC model, single lab","pmids":["38654563"],"is_preprint":false},{"year":2022,"finding":"miR-129-5p promotes osteogenic differentiation by directly targeting and inhibiting PKIA, thereby activating PKA and increasing phosphorylation of β-catenin and CREB. Dual-luciferase reporter assays confirmed PKIA as a direct miR-129-5p target; PKA inhibitor H89 blocked the osteogenic effects of miR-129-5p overexpression.","method":"miR-129-5p mimic/inhibitor transfection; dual-luciferase reporter assay for miR-129-5p–PKIA interaction; PKA activity ELISA; Western blot for β-catenin and CREB phosphorylation; ALP activity assay; alizarin red staining; H89 rescue experiment; in vivo heterotopic implantation","journal":"Journal of periodontal research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct target validation by luciferase, pharmacological rescue with H89, in vivo confirmation, single lab","pmids":["36222334"],"is_preprint":false},{"year":2000,"finding":"Human PKIA is specifically expressed as two transcripts (3.3 kb and 1.5 kb) in heart and skeletal muscle, with distinct tissue distribution from paralogs PKIB and PKIG. Both the pseudosubstrate site and leucine-rich nuclear export signal (NES) motifs are conserved across 11 PKI proteins from different species.","method":"Northern blot analysis of PKIA, PKIB, and PKIG across multiple human tissues; sequence alignment of 11 PKI proteins to define conserved pseudosubstrate and NES motifs","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — northern blot defining tissue-specific expression and sequence-based identification of conserved functional domains, replicated across multiple tissues","pmids":["10880337"],"is_preprint":false},{"year":2010,"finding":"The PKIA nuclear export signal (NES) is a well-defined CRM1-binding leucine-rich motif. Substituting the PKIA NES into AMPKα restored cytoplasmic localization of an AMPKα mutant lacking its own NES, demonstrating that the PKIA NES is functionally sufficient for CRM1-dependent nuclear export.","method":"Substitution of PKIA NES into Drosophila AMPKα; leptomycin B treatment; transgenic Drosophila complementation assay; fluorescence localization imaging","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional NES substitution in vivo in transgenic Drosophila with leptomycin B validation, single lab","pmids":["20685962"],"is_preprint":false},{"year":2013,"finding":"The PKIA NES is functionally sufficient for CRM1-dependent nuclear export: fusion of the PKIA NES (or NES motifs from ABL1, Rev, APC) in-frame with AF10 was sufficient to immortalize murine hematopoietic progenitors and drive HOXA gene upregulation and H3K79 hypomethylation, phenocopying the oncogenic CALM-AF10 fusion.","method":"Retroviral transduction of NES-AF10 constructs (including PKIA NES) into murine hematopoietic progenitors; colony-forming assay; gene expression analysis; leptomycin B treatment","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transplantability of PKIA NES demonstrated in cellular transformation assay with leptomycin B confirmation, single lab","pmids":["23487024"],"is_preprint":false},{"year":2023,"finding":"miR-10a-3p, enriched in melatonin-primed MSC-derived small extracellular vesicles, directly targets PKIA. Suppression of miR-10a-3p abolished therapeutic effects (erectile function restoration, inhibition of RhoA/ROCK signaling, prevention of smooth muscle phenotypic modulation), which were rescued by PKIA overexpression, placing PKIA upstream of RhoA/ROCK in cavernous nerve injury.","method":"miR-10a-3p inhibition and PKIA overexpression in CNI ED rats; measurement of erectile function; Western blot for RhoA/ROCK pathway; sequencing of sEV miRNA content","journal":"Advanced healthcare materials","confidence":"Low","confidence_rationale":"Tier 3 / Weak — genetic rescue placing PKIA in RhoA/ROCK pathway, but direct miR-10a-3p–PKIA binding not validated by luciferase in this paper; single lab","pmids":["36652551"],"is_preprint":false},{"year":2007,"finding":"PKIA (PKI-alpha) expression is increased in medial prefrontal cortex, nucleus accumbens, and amygdala during chronic intermittent alcohol exposure, coinciding with downregulation of multiple PKA-regulated transcripts (Ania-1, -3, -7, -8, Egr1, Nr4a1, NPY), consistent with PKIA acting as a suppressor of nuclear PKA activity in these brain regions.","method":"High-density oligonucleotide microarrays with independent RT-PCR validation in three brain regions of alcohol-exposed rats","journal":"Brain research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative expression evidence (microarray + RT-PCR), no direct mechanistic manipulation of PKIA","pmids":["17270154"],"is_preprint":false}],"current_model":"PKIA (PKIα) is an endogenous inhibitor of cAMP-dependent protein kinase A (PKA) that binds PKA catalytic subunits via a pseudosubstrate motif to block kinase activity; it contains a leucine-rich nuclear export signal (NES) that mediates CRM1-dependent cytoplasmic retention; by suppressing PKA, PKIA elevates intracellular cAMP and diverts cAMP signaling toward EPAC-Rap1-ERK, thereby modulating cell growth, hypertrophy, osteogenesis, and chemoresistance, and its expression is transcriptionally regulated by the SIRT1/FOXO3 axis and post-transcriptionally by miRNAs including miR-129 and miR-10a-3p."},"narrative":{"mechanistic_narrative":"PKIA (PKIα) is an endogenous pseudosubstrate inhibitor of cAMP-dependent protein kinase A (PKA) that, by binding and blocking PKA catalytic activity, reroutes GPCR–Gαs–cAMP signaling away from PKA and toward the noncanonical EPAC–Rap1–ERK axis to control cell growth, survival, and migration [PMID:32830375]. Because PKIA suppresses PKA-mediated negative feedback on cAMP, its overexpression paradoxically raises intracellular cAMP while lowering PKA activity, an arrangement that drives tumor cell migration, anoikis resistance, and drug efflux—exemplified in prostate cancer [PMID:32830375] and in vincristine-resistant Ewing sarcoma, where PKIA-driven EPAC signaling confers chemoresistance reversible by EPAC inhibition or PKIA knockdown [PMID:41313792]. In the heart, PKIA acts as a brake on PKA: its loss permits PKA-dependent DRP1 phosphorylation, mitochondrial fusion, and protection against cardiomyocyte hypertrophy, while its induction attenuates hypertrophy [PMID:32152556, PMID:38654563]. PKIA also gates PKA-dependent osteogenic differentiation through β-catenin and CREB phosphorylation [PMID:36222334]. Beyond PKA inhibition, PKIA carries a leucine-rich, CRM1-dependent nuclear export signal that is functionally sufficient to direct cytoplasmic localization and, when transplanted, to drive CRM1-dependent nuclear export of heterologous proteins [PMID:20685962, PMID:23487024]. PKIA expression is tissue-restricted, with strongest transcripts in heart and skeletal muscle [PMID:10880337], and is controlled transcriptionally by the SIRT1/FOXO3 axis [PMID:38654563] and post-transcriptionally by miRNAs including miR-129/miR-129-5p [PMID:32152556, PMID:36222334] and miR-10a-3p [PMID:36652551].","teleology":[{"year":2000,"claim":"Establishing that human PKIA is a distinct, tissue-restricted family member with conserved functional motifs separated it from its paralogs and defined the structural elements underlying its dual activity.","evidence":"Northern blot across human tissues plus sequence alignment of 11 PKI proteins defining conserved pseudosubstrate and NES motifs","pmids":["10880337"],"confidence":"Medium","gaps":["Does not test the functional output of either motif","No protein-level localization or PKA-binding data"]},{"year":2007,"claim":"Correlating PKIA induction with loss of PKA-responsive transcripts in brain provided the first in vivo link between PKIA levels and suppression of nuclear PKA activity.","evidence":"Microarray and RT-PCR in three brain regions of chronic alcohol-exposed rats","pmids":["17270154"],"confidence":"Low","gaps":["Correlative only—no direct manipulation of PKIA","Causal link between PKIA and the downregulated transcripts not established"]},{"year":2010,"claim":"Demonstrating that the PKIA NES alone restores cytoplasmic localization established it as a portable, CRM1-dependent export signal independent of PKA binding.","evidence":"Substitution of the PKIA NES into a Drosophila AMPKα export mutant with leptomycin B sensitivity testing","pmids":["20685962"],"confidence":"Medium","gaps":["Tested in a heterologous protein, not endogenous PKIA","Does not address how NES activity is regulated"]},{"year":2013,"claim":"Showing the PKIA NES could substitute for oncogenic fusion NES motifs confirmed its export function is strong and transplantable, decoupling the NES from PKIA's kinase-inhibitory role.","evidence":"Retroviral NES-AF10 fusion constructs transforming murine hematopoietic progenitors with leptomycin B confirmation","pmids":["23487024"],"confidence":"Medium","gaps":["Uses the isolated NES motif, not full-length PKIA","Does not implicate endogenous PKIA in leukemogenesis"]},{"year":2020,"claim":"Direct overexpression and depletion established the central paradox—that PKIA raises cAMP while inhibiting PKA—and placed it as a driver of EPAC-Rap1-ERK signaling and tumor cell migration/survival.","evidence":"PKIA OE/knockdown in prostate cancer cells with cAMP, EPAC-RAP1, ERK, migration, anoikis, and tumor growth readouts","pmids":["32830375"],"confidence":"Medium","gaps":["Single lab and largely one cancer context","Mechanism by which EPAC drives migration not dissected"]},{"year":2020,"claim":"Identifying miR-129 as a repressor of PKIA connected PKIA suppression to PKA-dependent mitochondrial fusion and anti-hypertrophic protection in cardiomyocytes.","evidence":"RNA-seq, miR-129 gain/loss, PKA activity assays, and mitochondrial morphology/calcium readouts in an angiotensin-(1-9) hypertrophy model","pmids":["32152556"],"confidence":"Medium","gaps":["Direct miR-129–PKIA binding not luciferase-validated here","DRP1 phosphorylation linkage inferred from pathway activity"]},{"year":2022,"claim":"Direct target validation showed miR-129-5p represses PKIA to de-repress PKA-driven β-catenin/CREB phosphorylation and osteogenic differentiation, extending the PKIA-PKA axis to differentiation control.","evidence":"miR-129-5p mimic/inhibitor, dual-luciferase PKIA target assay, PKA ELISA, H89 rescue, and in vivo heterotopic implantation","pmids":["36222334"],"confidence":"Medium","gaps":["Does not distinguish nuclear vs cytoplasmic PKA pools","Cell-type generality beyond the studied MSC model untested"]},{"year":2023,"claim":"Placing PKIA upstream of RhoA/ROCK via miR-10a-3p extended its regulatory reach to smooth muscle phenotype in a therapeutic extracellular-vesicle context.","evidence":"miR-10a-3p inhibition with PKIA overexpression rescue in a cavernous nerve injury rat model, with RhoA/ROCK readouts","pmids":["36652551"],"confidence":"Low","gaps":["Direct miR-10a-3p–PKIA binding not validated by luciferase","Mechanistic link from PKIA to RhoA/ROCK not resolved"]},{"year":2024,"claim":"Defining the SIRT1/FOXO3 axis as a direct transcriptional activator of PKIA established an upstream control circuit for its anti-hypertrophic, PKA-suppressing function.","evidence":"SIRT1/FOXO3 OE/silencing in Ang II-treated H9C2 cells, FOXO3-PKIA promoter luciferase assay, and a TAC rat model","pmids":["38654563"],"confidence":"Medium","gaps":["Does not reconcile cardioprotective PKIA induction with pro-tumor PKIA roles","Other transcriptional regulators not surveyed"]},{"year":2024,"claim":"Demonstrating PKIA-driven EPAC-Rap1-ERK signaling promotes drug efflux and chemoresistance, reversible pharmacologically, defined a therapeutically actionable mechanism in sarcoma.","evidence":"PKIA OE/knockdown, cAMP/PKA measurements, EPAC inhibitor (ESI-09) treatment, IC50 assays, and xenografts in vincristine-resistant Ewing sarcoma","pmids":["41313792"],"confidence":"Medium","gaps":["Single cancer type and single lab","Drug efflux transporter linkage downstream of EPAC not fully defined"]},{"year":null,"claim":"How PKIA's cytoplasmic NES-driven retention is coordinated with its PKA-inhibitory activity, and what reconciles its opposing roles across cardiac protection versus tumor promotion, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of full-length PKIA bound to PKA in the corpus","No reconciliation of context-dependent pro- vs anti-growth outcomes","Regulation linking NES export to PKA inhibition uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,7,9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,2]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4]}],"complexes":[],"partners":["PRKACA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P61925","full_name":"cAMP-dependent protein kinase inhibitor alpha","aliases":["cAMP-dependent protein kinase inhibitor, muscle/brain isoform"],"length_aa":76,"mass_kda":8.0,"function":"Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P61925/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PKIA","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PRKACA","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PKIA","total_profiled":1310},"omim":[{"mim_id":"606059","title":"PROTEIN KINASE, cAMP-DEPENDENT CATALYTIC, INHIBITOR ALPHA; PKIA","url":"https://www.omim.org/entry/606059"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"skeletal muscle","ntpm":1087.6},{"tissue":"tongue","ntpm":889.8}],"url":"https://www.proteinatlas.org/search/PKIA"},"hgnc":{"alias_symbol":[],"prev_symbol":["PRKACN1"]},"alphafold":{"accession":"P61925","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P61925","model_url":"https://alphafold.ebi.ac.uk/files/AF-P61925-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P61925-F1-predicted_aligned_error_v6.png","plddt_mean":65.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PKIA","jax_strain_url":"https://www.jax.org/strain/search?query=PKIA"},"sequence":{"accession":"P61925","fasta_url":"https://rest.uniprot.org/uniprotkb/P61925.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P61925/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P61925"}},"corpus_meta":[{"pmid":"20685962","id":"PMC_20685962","title":"Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20685962","citation_count":96,"is_preprint":false},{"pmid":"20451256","id":"PMC_20451256","title":"A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample.","date":"2010","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/20451256","citation_count":96,"is_preprint":false},{"pmid":"2839306","id":"PMC_2839306","title":"Isolation and transformation of the pyruvate kinase gene of Aspergillus nidulans.","date":"1988","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2839306","citation_count":70,"is_preprint":false},{"pmid":"32379964","id":"PMC_32379964","title":"Improved Production of Malic Acid in Aspergillus niger by Abolishing Citric Acid Accumulation and Enhancing Glycolytic Flux.","date":"2020","source":"ACS synthetic biology","url":"https://pubmed.ncbi.nlm.nih.gov/32379964","citation_count":60,"is_preprint":false},{"pmid":"11157212","id":"PMC_11157212","title":"Combined molecular and biochemical approach identifies Aspergillus japonicus and Aspergillus aculeatus as two species.","date":"2001","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11157212","citation_count":50,"is_preprint":false},{"pmid":"32152556","id":"PMC_32152556","title":"Angiotensin-(1-9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32152556","citation_count":44,"is_preprint":false},{"pmid":"8384884","id":"PMC_8384884","title":"Phosphorylation is involved in transcriptional activation by the 1,25-dihydroxyvitamin D3 receptor.","date":"1993","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8384884","citation_count":40,"is_preprint":false},{"pmid":"1611667","id":"PMC_1611667","title":"Isolation and characterization of the Aspergillus niger pyruvate kinase gene.","date":"1992","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1611667","citation_count":38,"is_preprint":false},{"pmid":"32830375","id":"PMC_32830375","title":"Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32830375","citation_count":33,"is_preprint":false},{"pmid":"23487024","id":"PMC_23487024","title":"A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23487024","citation_count":31,"is_preprint":false},{"pmid":"30873006","id":"PMC_30873006","title":"Silencing of lncRNA PKIA-AS1 Attenuates Spinal Nerve Ligation-Induced Neuropathic Pain Through Epigenetic Downregulation of CDK6 Expression.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30873006","citation_count":29,"is_preprint":false},{"pmid":"18445752","id":"PMC_18445752","title":"Molecular correlates for maximal oxygen uptake and type 1 fibers.","date":"2008","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18445752","citation_count":26,"is_preprint":false},{"pmid":"17270154","id":"PMC_17270154","title":"Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17270154","citation_count":25,"is_preprint":false},{"pmid":"10880337","id":"PMC_10880337","title":"Cloning and mapping of human PKIB and PKIG, and comparison of tissue expression patterns of three members of the protein kinase inhibitor family, including PKIA.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10880337","citation_count":23,"is_preprint":false},{"pmid":"19908039","id":"PMC_19908039","title":"A novel expression system for intracellular production and purification of recombinant affinity-tagged proteins in Aspergillus niger.","date":"2009","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/19908039","citation_count":19,"is_preprint":false},{"pmid":"1633170","id":"PMC_1633170","title":"Steady-state kinetics and isotope effects on the mutant catalytic trimer of aspartate transcarbamoylase containing the replacement of histidine 134 by alanine.","date":"1992","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1633170","citation_count":17,"is_preprint":false},{"pmid":"31279709","id":"PMC_31279709","title":"An integrated approach for mining precise RNA-based cervical cancer staging biomarkers.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31279709","citation_count":14,"is_preprint":false},{"pmid":"36652551","id":"PMC_36652551","title":"Melatonin-Primed Mesenchymal Stem Cells-Derived Small Extracellular Vesicles Alleviated Neurogenic Erectile Dysfunction by Reversing Phenotypic Modulation.","date":"2023","source":"Advanced healthcare materials","url":"https://pubmed.ncbi.nlm.nih.gov/36652551","citation_count":13,"is_preprint":false},{"pmid":"30291431","id":"PMC_30291431","title":"Carbocisteine stimulated an increase in ciliary bend angle via a decrease in [Cl-]i in mouse airway cilia.","date":"2018","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30291431","citation_count":13,"is_preprint":false},{"pmid":"8359694","id":"PMC_8359694","title":"Characterization of the pyruvate kinase-encoding gene (pki1) of Trichoderma reesei.","date":"1993","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8359694","citation_count":13,"is_preprint":false},{"pmid":"35610231","id":"PMC_35610231","title":"The regulatory mechanism of LncRNA-mediated ceRNA network in osteosarcoma.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35610231","citation_count":10,"is_preprint":false},{"pmid":"33867976","id":"PMC_33867976","title":"An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Xiong-Pi-Fang in Treating Coronary Heart Disease with Depression.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33867976","citation_count":10,"is_preprint":false},{"pmid":"24910983","id":"PMC_24910983","title":"Highly expressed protein kinase A inhibitor α and suppression of protein kinase A may potentiate acetaminophen-induced hepatotoxicity.","date":"2014","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24910983","citation_count":8,"is_preprint":false},{"pmid":"37644544","id":"PMC_37644544","title":"Exploring the methylation status of CFTR and PKIA genes as potential biomarkers for lung adenocarcinoma.","date":"2023","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37644544","citation_count":6,"is_preprint":false},{"pmid":"36222334","id":"PMC_36222334","title":"A grooved porous hydroxyapatite scaffold induces osteogenic differentiation via regulation of PKA activity by upregulating miR-129-5p expression.","date":"2022","source":"Journal of periodontal research","url":"https://pubmed.ncbi.nlm.nih.gov/36222334","citation_count":6,"is_preprint":false},{"pmid":"33644266","id":"PMC_33644266","title":"Molecular characterization of the stress network in individuals at risk for schizophrenia.","date":"2021","source":"Neurobiology of stress","url":"https://pubmed.ncbi.nlm.nih.gov/33644266","citation_count":6,"is_preprint":false},{"pmid":"38654563","id":"PMC_38654563","title":"Dronedarone Attenuates Ang II-Induced Myocardial Hypertrophy Through Regulating SIRT1/FOXO3/PKIA Axis.","date":"2024","source":"Korean circulation journal","url":"https://pubmed.ncbi.nlm.nih.gov/38654563","citation_count":4,"is_preprint":false},{"pmid":"33885249","id":"PMC_33885249","title":"Glucose deprivation affects the expression of genes encoding cAMP-activated protein kinase and related proteins in U87 glioma cells in ERN1 dependent manner.","date":"2020","source":"Endocrine regulations","url":"https://pubmed.ncbi.nlm.nih.gov/33885249","citation_count":4,"is_preprint":false},{"pmid":"34289228","id":"PMC_34289228","title":"An Epigenetic Signature is Associated with Serum 25-Hydroxyvitamin D in Colorectal Cancer Tumors.","date":"2021","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/34289228","citation_count":3,"is_preprint":false},{"pmid":"38650880","id":"PMC_38650880","title":"Transcriptional dynamics and regulatory function of milRNAs in Ascosphaera apis invading Apis mellifera larvae.","date":"2024","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/38650880","citation_count":2,"is_preprint":false},{"pmid":"40272615","id":"PMC_40272615","title":"Multiple data sets to explore the key molecules and mechanism of lymph node metastasis in gastric cancer.","date":"2025","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/40272615","citation_count":1,"is_preprint":false},{"pmid":"40821334","id":"PMC_40821334","title":"PFKP Mediates Breast Cancer Metastasis Through Altered Glycolysis.","date":"2025","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/40821334","citation_count":0,"is_preprint":false},{"pmid":"41313792","id":"PMC_41313792","title":"Protein Kinase Inhibitor Alpha Drives Vincristine Resistance in Ewing Sarcoma via cAMP-EPAC Signaling Reprogramming.","date":"2025","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/41313792","citation_count":0,"is_preprint":false},{"pmid":"42177950","id":"PMC_42177950","title":"Ascosphaeraapis LncRNA6140 promotes the infection of honeybee larvae through the milR5658-x-ATPase axis.","date":"2026","source":"Insect biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/42177950","citation_count":0,"is_preprint":false},{"pmid":"34486555","id":"PMC_34486555","title":"T-cell Lymphoblastic Lymphoma in a Patient With Chromosome 8q21.11 Microdeletion.","date":"2022","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34486555","citation_count":0,"is_preprint":false},{"pmid":"1212447","id":"PMC_1212447","title":"[Different forms of pyruvate kinase from the rabbit adrenal cortex].","date":"1975","source":"Biokhimiia (Moscow, Russia)","url":"https://pubmed.ncbi.nlm.nih.gov/1212447","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19809,"output_tokens":2961,"usd":0.051921,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10347,"output_tokens":3597,"usd":0.07083,"stage2_stop_reason":"end_turn"},"total_usd":0.122751,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"PKIA (PKIα) binds PKA with high affinity and blocks its kinase activity, thereby diverting GPCR-Gαs-cAMP signaling away from PKA and toward EPAC-RAP1 and MAPK activation. Overexpression of PKIA increases intracellular cAMP (by relieving PKA-mediated negative feedback on cAMP), enhances EPAC and ERK activation, and promotes tumor cell migration and growth. Depletion of PKIA in prostate cancer cells reduces migration, increases sensitivity to anoikis, and reduces tumor growth.\",\n      \"method\": \"PKI overexpression and depletion (knockdown) in cell lines measuring MAPK pathway activation, cAMP levels, EPAC-RAP1 activation, migration assay, anoikis assay, tumor growth assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO/OE with defined cellular phenotype and pathway placement (EPAC-RAP1-ERK), multiple orthogonal readouts in a single lab\",\n      \"pmids\": [\"32830375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Angiotensin-(1-9) upregulates miR-129, which decreases PKIA transcript levels, resulting in activation of PKA signaling. PKA activity downstream of PKIA suppression is necessary for angiotensin-(1-9)-mediated mitochondrial fusion (via DRP1 phosphorylation), prevention of mitochondrial fission and calcium dysregulation, and anti-hypertrophic effects on cardiomyocytes.\",\n      \"method\": \"RNA-seq to identify miR-129 upregulation; miR-129 overexpression/inhibition; Western blot for PKIA and PKA targets; PKA activity assays; measurement of mitochondrial morphology and calcium handling; calcineurin/NFAT pathway readouts in cardiomyocyte hypertrophy model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (RNA-seq, functional miRNA manipulation, PKA activity measurement, mitochondrial morphology), single lab\",\n      \"pmids\": [\"32152556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PKIA overexpression elevates intracellular cAMP but suppresses PKA activity, instead activating the noncanonical EPAC-Rap1-ERK pathway to promote drug efflux and cell survival in vincristine-resistant Ewing sarcoma. Pharmacological inhibition of EPAC reversed resistance, and PKIA knockdown restored vincristine sensitivity in xenografts.\",\n      \"method\": \"Transcriptomic analysis of vincristine-resistant cells; PKIA overexpression and knockdown; cAMP and PKA activity measurements; EPAC inhibitor (ESI-09) treatment; IC50 assays; xenograft models\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO/OE with defined pathway (cAMP-EPAC-Rap1-ERK), in vivo xenograft validation, pharmacological rescue, single lab\",\n      \"pmids\": [\"41313792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Dronedarone activates SIRT1, which deacetylates FOXO3, leading to FOXO3 transcriptional upregulation of PKIA. Elevated PKIA in turn suppresses PKA activity and attenuates myocardial hypertrophy. JASPAR/luciferase assays confirmed FOXO3 binding to the PKIA promoter.\",\n      \"method\": \"SIRT1/FOXO3 overexpression and silencing in Ang II-treated H9C2 cells; JASPAR prediction and luciferase reporter assay for FOXO3-PKIA promoter interaction; RT-qPCR and Western blot; TAC rat model; crystal violet and rhodamine phalloidin staining for cell size\",\n      \"journal\": \"Korean circulation journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter validates direct promoter binding, multiple genetic manipulations, in vivo TAC model, single lab\",\n      \"pmids\": [\"38654563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-129-5p promotes osteogenic differentiation by directly targeting and inhibiting PKIA, thereby activating PKA and increasing phosphorylation of β-catenin and CREB. Dual-luciferase reporter assays confirmed PKIA as a direct miR-129-5p target; PKA inhibitor H89 blocked the osteogenic effects of miR-129-5p overexpression.\",\n      \"method\": \"miR-129-5p mimic/inhibitor transfection; dual-luciferase reporter assay for miR-129-5p–PKIA interaction; PKA activity ELISA; Western blot for β-catenin and CREB phosphorylation; ALP activity assay; alizarin red staining; H89 rescue experiment; in vivo heterotopic implantation\",\n      \"journal\": \"Journal of periodontal research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct target validation by luciferase, pharmacological rescue with H89, in vivo confirmation, single lab\",\n      \"pmids\": [\"36222334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Human PKIA is specifically expressed as two transcripts (3.3 kb and 1.5 kb) in heart and skeletal muscle, with distinct tissue distribution from paralogs PKIB and PKIG. Both the pseudosubstrate site and leucine-rich nuclear export signal (NES) motifs are conserved across 11 PKI proteins from different species.\",\n      \"method\": \"Northern blot analysis of PKIA, PKIB, and PKIG across multiple human tissues; sequence alignment of 11 PKI proteins to define conserved pseudosubstrate and NES motifs\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — northern blot defining tissue-specific expression and sequence-based identification of conserved functional domains, replicated across multiple tissues\",\n      \"pmids\": [\"10880337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The PKIA nuclear export signal (NES) is a well-defined CRM1-binding leucine-rich motif. Substituting the PKIA NES into AMPKα restored cytoplasmic localization of an AMPKα mutant lacking its own NES, demonstrating that the PKIA NES is functionally sufficient for CRM1-dependent nuclear export.\",\n      \"method\": \"Substitution of PKIA NES into Drosophila AMPKα; leptomycin B treatment; transgenic Drosophila complementation assay; fluorescence localization imaging\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional NES substitution in vivo in transgenic Drosophila with leptomycin B validation, single lab\",\n      \"pmids\": [\"20685962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The PKIA NES is functionally sufficient for CRM1-dependent nuclear export: fusion of the PKIA NES (or NES motifs from ABL1, Rev, APC) in-frame with AF10 was sufficient to immortalize murine hematopoietic progenitors and drive HOXA gene upregulation and H3K79 hypomethylation, phenocopying the oncogenic CALM-AF10 fusion.\",\n      \"method\": \"Retroviral transduction of NES-AF10 constructs (including PKIA NES) into murine hematopoietic progenitors; colony-forming assay; gene expression analysis; leptomycin B treatment\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transplantability of PKIA NES demonstrated in cellular transformation assay with leptomycin B confirmation, single lab\",\n      \"pmids\": [\"23487024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"miR-10a-3p, enriched in melatonin-primed MSC-derived small extracellular vesicles, directly targets PKIA. Suppression of miR-10a-3p abolished therapeutic effects (erectile function restoration, inhibition of RhoA/ROCK signaling, prevention of smooth muscle phenotypic modulation), which were rescued by PKIA overexpression, placing PKIA upstream of RhoA/ROCK in cavernous nerve injury.\",\n      \"method\": \"miR-10a-3p inhibition and PKIA overexpression in CNI ED rats; measurement of erectile function; Western blot for RhoA/ROCK pathway; sequencing of sEV miRNA content\",\n      \"journal\": \"Advanced healthcare materials\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — genetic rescue placing PKIA in RhoA/ROCK pathway, but direct miR-10a-3p–PKIA binding not validated by luciferase in this paper; single lab\",\n      \"pmids\": [\"36652551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PKIA (PKI-alpha) expression is increased in medial prefrontal cortex, nucleus accumbens, and amygdala during chronic intermittent alcohol exposure, coinciding with downregulation of multiple PKA-regulated transcripts (Ania-1, -3, -7, -8, Egr1, Nr4a1, NPY), consistent with PKIA acting as a suppressor of nuclear PKA activity in these brain regions.\",\n      \"method\": \"High-density oligonucleotide microarrays with independent RT-PCR validation in three brain regions of alcohol-exposed rats\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative expression evidence (microarray + RT-PCR), no direct mechanistic manipulation of PKIA\",\n      \"pmids\": [\"17270154\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PKIA (PKIα) is an endogenous inhibitor of cAMP-dependent protein kinase A (PKA) that binds PKA catalytic subunits via a pseudosubstrate motif to block kinase activity; it contains a leucine-rich nuclear export signal (NES) that mediates CRM1-dependent cytoplasmic retention; by suppressing PKA, PKIA elevates intracellular cAMP and diverts cAMP signaling toward EPAC-Rap1-ERK, thereby modulating cell growth, hypertrophy, osteogenesis, and chemoresistance, and its expression is transcriptionally regulated by the SIRT1/FOXO3 axis and post-transcriptionally by miRNAs including miR-129 and miR-10a-3p.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PKIA (PKIα) is an endogenous pseudosubstrate inhibitor of cAMP-dependent protein kinase A (PKA) that, by binding and blocking PKA catalytic activity, reroutes GPCR–Gαs–cAMP signaling away from PKA and toward the noncanonical EPAC–Rap1–ERK axis to control cell growth, survival, and migration [#0]. Because PKIA suppresses PKA-mediated negative feedback on cAMP, its overexpression paradoxically raises intracellular cAMP while lowering PKA activity, an arrangement that drives tumor cell migration, anoikis resistance, and drug efflux—exemplified in prostate cancer [#0] and in vincristine-resistant Ewing sarcoma, where PKIA-driven EPAC signaling confers chemoresistance reversible by EPAC inhibition or PKIA knockdown [#2]. In the heart, PKIA acts as a brake on PKA: its loss permits PKA-dependent DRP1 phosphorylation, mitochondrial fusion, and protection against cardiomyocyte hypertrophy, while its induction attenuates hypertrophy [#1, #3]. PKIA also gates PKA-dependent osteogenic differentiation through β-catenin and CREB phosphorylation [#4]. Beyond PKA inhibition, PKIA carries a leucine-rich, CRM1-dependent nuclear export signal that is functionally sufficient to direct cytoplasmic localization and, when transplanted, to drive CRM1-dependent nuclear export of heterologous proteins [#6, #7]. PKIA expression is tissue-restricted, with strongest transcripts in heart and skeletal muscle [#5], and is controlled transcriptionally by the SIRT1/FOXO3 axis [#3] and post-transcriptionally by miRNAs including miR-129/miR-129-5p [#1, #4] and miR-10a-3p [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that human PKIA is a distinct, tissue-restricted family member with conserved functional motifs separated it from its paralogs and defined the structural elements underlying its dual activity.\",\n      \"evidence\": \"Northern blot across human tissues plus sequence alignment of 11 PKI proteins defining conserved pseudosubstrate and NES motifs\",\n      \"pmids\": [\"10880337\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not test the functional output of either motif\", \"No protein-level localization or PKA-binding data\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Correlating PKIA induction with loss of PKA-responsive transcripts in brain provided the first in vivo link between PKIA levels and suppression of nuclear PKA activity.\",\n      \"evidence\": \"Microarray and RT-PCR in three brain regions of chronic alcohol-exposed rats\",\n      \"pmids\": [\"17270154\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Correlative only—no direct manipulation of PKIA\", \"Causal link between PKIA and the downregulated transcripts not established\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that the PKIA NES alone restores cytoplasmic localization established it as a portable, CRM1-dependent export signal independent of PKA binding.\",\n      \"evidence\": \"Substitution of the PKIA NES into a Drosophila AMPKα export mutant with leptomycin B sensitivity testing\",\n      \"pmids\": [\"20685962\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tested in a heterologous protein, not endogenous PKIA\", \"Does not address how NES activity is regulated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showing the PKIA NES could substitute for oncogenic fusion NES motifs confirmed its export function is strong and transplantable, decoupling the NES from PKIA's kinase-inhibitory role.\",\n      \"evidence\": \"Retroviral NES-AF10 fusion constructs transforming murine hematopoietic progenitors with leptomycin B confirmation\",\n      \"pmids\": [\"23487024\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Uses the isolated NES motif, not full-length PKIA\", \"Does not implicate endogenous PKIA in leukemogenesis\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Direct overexpression and depletion established the central paradox—that PKIA raises cAMP while inhibiting PKA—and placed it as a driver of EPAC-Rap1-ERK signaling and tumor cell migration/survival.\",\n      \"evidence\": \"PKIA OE/knockdown in prostate cancer cells with cAMP, EPAC-RAP1, ERK, migration, anoikis, and tumor growth readouts\",\n      \"pmids\": [\"32830375\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab and largely one cancer context\", \"Mechanism by which EPAC drives migration not dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying miR-129 as a repressor of PKIA connected PKIA suppression to PKA-dependent mitochondrial fusion and anti-hypertrophic protection in cardiomyocytes.\",\n      \"evidence\": \"RNA-seq, miR-129 gain/loss, PKA activity assays, and mitochondrial morphology/calcium readouts in an angiotensin-(1-9) hypertrophy model\",\n      \"pmids\": [\"32152556\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct miR-129–PKIA binding not luciferase-validated here\", \"DRP1 phosphorylation linkage inferred from pathway activity\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Direct target validation showed miR-129-5p represses PKIA to de-repress PKA-driven β-catenin/CREB phosphorylation and osteogenic differentiation, extending the PKIA-PKA axis to differentiation control.\",\n      \"evidence\": \"miR-129-5p mimic/inhibitor, dual-luciferase PKIA target assay, PKA ELISA, H89 rescue, and in vivo heterotopic implantation\",\n      \"pmids\": [\"36222334\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not distinguish nuclear vs cytoplasmic PKA pools\", \"Cell-type generality beyond the studied MSC model untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placing PKIA upstream of RhoA/ROCK via miR-10a-3p extended its regulatory reach to smooth muscle phenotype in a therapeutic extracellular-vesicle context.\",\n      \"evidence\": \"miR-10a-3p inhibition with PKIA overexpression rescue in a cavernous nerve injury rat model, with RhoA/ROCK readouts\",\n      \"pmids\": [\"36652551\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct miR-10a-3p–PKIA binding not validated by luciferase\", \"Mechanistic link from PKIA to RhoA/ROCK not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defining the SIRT1/FOXO3 axis as a direct transcriptional activator of PKIA established an upstream control circuit for its anti-hypertrophic, PKA-suppressing function.\",\n      \"evidence\": \"SIRT1/FOXO3 OE/silencing in Ang II-treated H9C2 cells, FOXO3-PKIA promoter luciferase assay, and a TAC rat model\",\n      \"pmids\": [\"38654563\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not reconcile cardioprotective PKIA induction with pro-tumor PKIA roles\", \"Other transcriptional regulators not surveyed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating PKIA-driven EPAC-Rap1-ERK signaling promotes drug efflux and chemoresistance, reversible pharmacologically, defined a therapeutically actionable mechanism in sarcoma.\",\n      \"evidence\": \"PKIA OE/knockdown, cAMP/PKA measurements, EPAC inhibitor (ESI-09) treatment, IC50 assays, and xenografts in vincristine-resistant Ewing sarcoma\",\n      \"pmids\": [\"41313792\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cancer type and single lab\", \"Drug efflux transporter linkage downstream of EPAC not fully defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PKIA's cytoplasmic NES-driven retention is coordinated with its PKA-inhibitory activity, and what reconciles its opposing roles across cardiac protection versus tumor promotion, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of full-length PKIA bound to PKA in the corpus\", \"No reconciliation of context-dependent pro- vs anti-growth outcomes\", \"Regulation linking NES export to PKA inhibition uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 7, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PRKACA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}